GFM
PYXS icon

GF Fund Management’s Pyxis Oncology PYXS Stock Holding History

GF Fund Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Sell
1,226
-90
-7% -$172 ﹤0.01% 582
2026
Q1 		$1.92K Buy
1,316
+39
+3% +$59 ﹤0.01% 621
2025
Q4 		$1.47K Sell
1,277
-57
-4% -$201 ﹤0.01% 642
2025
Q3 		$2.96K Sell
1,334
-95
-7% -$137 ﹤0.01% 620
2025
Q2 		$1.57K Hold
1,429
– – ﹤0.01% 652
2025
Q1 		$1.4K Buy
1,429
+180
+14% +$240 ﹤0.01% 657
2024
Q4 		$1.95K Buy
+1,249
New +$3.6K ﹤0.01% 636

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's PYXS Position: Q2 2026 in Review

GF Fund Management reduced its Pyxis Oncology (PYXS) stake by 6.8% in Q2 2026, selling an estimated $172 and leaving 1,226 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

GF Fund Management first reported a position in PYXS in Q4 2024 and has held it in 7 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • GF Fund Management held 1,226 shares of Pyxis Oncology worth $3.69K as of Q2 2026.
  • GF Fund Management sold 90 Pyxis Oncology shares in Q2 2026, an estimated $172.
  • Pyxis Oncology made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #582 holding.
  • GF Fund Management first reported a position in Pyxis Oncology in Q4 2024 and has held it in 7 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.